Tech Company Financing Transactions
SpeechVive Funding Round
On 5/19/2016, SpeechVive announced $2.3 million in Seed funding from BioCrossroads, National Institutes of Health and private investors.
Transaction Overview
Company Name
Announced On
5/19/2016
Transaction Type
Venture Equity
Amount
$2,275,000
Round
Seed
Proceeds Purpose
The funds will be used to design, build and test a telehealth platform that enables speech pathologists to program the SpeechVive device from a remote location anywhere in the world. The telehealth platform will allow SpeechVive to reach elderly or physically impaired patients who cannot travel to speech pathologists.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
603 Wexford Dr.
Lafayette, IN 47905
USA
Lafayette, IN 47905
USA
Phone
Website
Email Address
Overview
SpeechVive detects when the patient is speaking using an accelerometer which is built into the earpiece. During speech, the device plays a background sound into the user's ear.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Mogensen
Chief Technical Officer
Jessica Huber
Browse more venture capital transactions:
Prev: 5/19/2016: CarePredict venture capital transaction
Next: 5/19/2016: Iterate.ai venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs